Skip to contentA
aTYR PHARMA INC
A
ATYRaTYR PHARMA INC Q1 2020 · 10-Q
Revenue$8.07M$8.07Mno prior Q1 2019 on file Net Income$1.75M$1.75MN/M vs Q1 2019 EPS Diluted$0.25$0.25N/M vs Q1 2019 Operating Income$1,859,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
Free Cash Flowderived$1,892,000N/M Margins · derivedOperating margin23.1%
Net margin21.7%
ended Mar 31, 2020 · filed May 12, 2020 · 42 d after period end